中文

China Mengniu Dairy Company Limited (02319) · Hong Kong stocks · Dairy Manufacturing and Distribution

Report date: 2026-10-07 | Price data: 2026-10-07 close | Sources: 28 | Report engine: v2 (latest)
View PDF Download Word Download Markdown

Latest market data

Close22.98 (-0.52% on the day; +6.98% over 5 sessions; +24.22% over 20 sessions)
Market capHKD 88.96 billion
P/E (last fiscal year)49.44x
P/B (MRQ)1.86x
P/S (last fiscal year)0.92x
52-week range14.13 (2025-12-11) – 23.38 (2026-11-18)
Moving averagesMA5 22.53 / MA10 21.98 / MA20 20.64 / MA60 18.94
MACD (12,26,9)DIF 1.139, DEA 0.939, histogram 0.401
RSIRSI6 85.3 / RSI14 79.3
Bollinger bands (20,2)Upper 24.13 / middle 20.64 / lower 17.14
Volume1x the 20-day average
One-week range (about 68% coverage)21.95 – 24.5 (-4.5% ~ +6.6%)
One-week range (about 95% coverage)21 – 25.96 (-8.6% ~ +13.0%)

As of the 2026-11-18 close; calculated from daily price data (unadjusted prices) and refreshed automatically each trading day. The one-week range reflects historical volatility only and is not a forecast. The report below was written on 2026-10-07; its prices and short-term scenarios reflect data at that time.

China Mengniu Dairy Company Limited (02319)

Equity Research Report | Industry: Dairy Manufacturing and Distribution | Report Date: October 7, 2026 | Market data as of the October 7, 2026 close

This report was automatically compiled by AI based on publicly available information and is for reference only. It does not constitute investment advice.

Key Conclusion: Earnings have begun to recover, but the drag from liquid milk and growth-based valuation assumptions still require validation

Key DataValue
Closing price (daily change)HKD 17.30 (+0.46%)
Total market capitalizationApproximately HKD 66.972 billion
PE (latest full fiscal year)37.04x
PB (latest period)1.41x
Dividend yieldApproximately 3.32%–3.35% (around October 2)
52-week rangeHKD 13.88–19.67
Trading value / turnover rateHKD 129 million / 0.19%

Market data as of the October 7, 2026 close

1. Key Investment Points

  • Earnings recovered in the first half, while gross margin edged down: Revenue increased 7.8% year over year in 1H 2026 and net profit attributable to shareholders rose 15.9%; gross margin was 40.8%, down approximately 0.99 percentage points year over year.
  • Stabilization in liquid milk is key to delivering growth: Liquid milk accounted for 78.9% of 2025 revenue and declined 11.1% year over year; cheese grew 21.9% and milk powder 9.7%, but their scale is not yet sufficient to offset pressure on the core business.
  • The current valuation requires a sustained earnings recovery: The closing price was HKD 17.30, with PE of 37.04x and PB of 1.41x; 26 analysts’ target prices range from HKD 18.29 to HKD 27.08.

Market Expectations and Evidence

  • What the market is pricing in: A PE of 37.04x implies average annual EPS growth of 19.3% if investors require a 9% annualized return and assume a 15x PE valuation in 10 years; consensus net profit growth is 11.2% in 2027 and 8.5% in 2028. The metrics and time horizons differ, so the figures are not directly comparable.
  • What the evidence shows: Revenue and profit returned to growth in 1H, but gross margin declined year over year; liquid milk still fell 11.1% in 2025. Available evidence supports a short-term recovery but has not yet validated the pricing assumption of 19.3% average annual EPS growth over 10 years.

Evidence assessment: Insufficient evidence; confidence: Low (some financial data fields still lack official verification or disclosure dates, and some arguments have conflicting periods or metrics; related judgments have been suppressed)

Some arguments involve inconsistent periods or metrics, so the relevant comparisons have been withdrawn.

2. Business and Competitive Position

2.1 Business Structure

Sells a broad range of dairy products to distributors, retailers, e-commerce platforms, and foodservice customers, using its brands, product mix, and channels to support pricing.

Business SegmentRevenue ShareGross MarginRevenue GrowthKey Points
Liquid milk78.9% (2025)—-11.1% (2025)Still accounts for nearly 80% of revenue; ambient milk is affected by weak demand and temporary capacity overhang
Ice cream6.6% (2025)—+4.2% (2025)Revenue returned to growth
Cheese6.4% (2025)—+21.9% (2025)Fast-growing value-added category
Milk powder4.4% (2025)—+9.7% (2025)Based on external revenue by segment, below the double-digit growth cited in the earnings announcement summary
Other3.7% (2025)—+7.5% (2025)Mainly includes dairy ingredient manufacturing and trading

2.2 Competitive Advantages

Competitive advantage strength: Medium

  • Brand and product portfolio: Covers brands and categories including Telunsu, Just Yoghurt, Shiny Meadow, cheese, and milk powder
  • Channel coverage: Expanding into membership stores, instant retail, e-commerce, B2B, and foodservice customers
  • Scale and network: Had annual capacity of 13.94 million tonnes in 2025 and production bases across multiple regions

Key threats: Weak liquid milk demand, temporary oversupply, and high channel marketing costs; falling revenue weakens economies of scale, while receivables impairment is increasing.

2.3 Value Chain Position and Profitability Trends

  • Core inputs include raw milk, as well as milk powder, sugar and other additives, cultures, and packaging materials. Raw milk prices are affected by industry supply and demand, and the company has limited control over procurement prices.
  • The 2025 earnings announcement did not disclose the procurement share of the top five suppliers; procurement scale and supply-chain collaboration may help reduce costs but do not imply absolute bargaining power.
  • Customers include distributors, retail and e-commerce channels, membership stores, restaurants, and foodservice customers; the company reaches consumers through multiple channels and brand partnerships.
  • Branded dairy companies face channel competition, promotions, and channel expense pressures; selling and distribution expenses accounted for 26.3% of revenue in 2025, while brand marketing expenses accounted for 9.0%.
  • The 2025 annual report stated that no single customer accounted for 10% or more of revenue, but did not disclose the combined share of the top five customers; this does not support a conclusion that customer concentration is low.
  • At the end of 2025, net receivables were 3.0% of revenue, with receivables turnover of approximately 12.6 days; payables were 16.0% of cost of sales. The provision for impairment of receivables rose to RMB 514.9 million, indicating increased collection risk.
Gross Margin / Net Margin-5.85%20.01%45.86%2021202220232024202536.74%35.30%37.15%39.57%39.89%5.70%4.88%0.12%1.88%Gross MarginNet Margin
Gross Margin / Net Margin
YearGross MarginNet MarginReasons for Change
202136.74%5.70%Revenue grew 15.9% and gross profit grew 13.1%, but gross margin remained slightly below 2020
202235.30%Approximately 5.73%Gross margin declined, indicating cost and product-mix pressures
202337.15%4.88%Gross margin recovered, while net margin attributable to shareholders remained below the prior year
202439.57%0.12%Raw milk prices and product mix were favorable, but impairments weighed on net profit attributable to shareholders
202539.89%1.88%Lower raw milk prices and an improved mix; falling revenue weakened economies of scale

Mengniu occupies a hybrid position between large-scale midstream processing and manufacturing and downstream branded channels. Raw milk costs have a significant impact on gross margin; profit improvement depends on stabilization in liquid milk, an upgraded product mix, greater channel expense efficiency, and control of receivables risk.

2.4 Industry and Peer Comparison

The dairy industry faces weak demand and temporary oversupply. Mengniu’s liquid milk revenue fell 11.1% in 2025; although lower raw milk prices and an improved product mix lifted gross margin, revenue contraction continued to weaken economies of scale.

CompanyPositioningComparable DataDifference from the Company
Yili Group (600887)Diversified dairy group, reasonably comparable to Mengniu in product categories and scale2025 revenue of RMB 115.6362 billion; gross margin of approximately 34.6%; PE (TTM) of 17.06xLarger scale; Mengniu had a higher gross margin in 2025
Bright Dairy (600597)Operates liquid milk, other dairy products, and livestock farming2025 revenue of RMB 23.8953 billion; gross margin of approximately 17.1%; PE (TTM) not applicable due to lossesSmaller scale, loss-making in 2025, and significantly lower gross margin
China Feihe (06186)Primarily focused on infant formula2025 revenue of RMB 18.1126 billion; gross margin of 65.0%; PE (latest full fiscal year) of 10.6xConcentrated in milk powder; its gross margin profile is not directly representative of a diversified dairy company

Mengniu has a diversified product portfolio, strong brands, and a cross-regional production network, and its gross margin in 2025 was higher than Yili’s. However, liquid milk accounts for nearly 80% of revenue, making the company notably exposed to weak demand. Its gross margin advantage has not yet translated fully into net margin, with expenses, impairments, and receivables risk continuing to affect earnings quality.

3. Financial Quality

3.1 Operating Performance

Reporting PeriodRevenueYoYNet Profit Attributable to ShareholdersYoYAdjusted YoYGross Margin
1H 2026RMB 44.795 billion+7.8%RMB 2.371 billion+15.9%—40.8%
FY 2025RMB 82.245 billion-7.3%RMB 1.545 billion+1,378.9%—39.9%
FY 2024RMB 88.675 billion-10.1%RMB 105 million-97.8%—39.6%

Interim data as of 2026-06-30; revenue is on a consolidated basis, profit is attributable to shareholders, and the currency is RMB. There is no consistently reconcilable disclosure of adjusted net profit.

Revenue and net profit attributable to shareholders returned to growth in 1H 2026, but gross margin fell approximately 0.99 percentage points year over year. The improvement in attributable profit was driven by an associate turning from loss to profit and improved operations; an RMB 320 million tax adjustment payment weighed on current-period profit. The sharp profit growth in 2025 was mainly due to the low base in 2024.

3.2 Financial Health Check

MetricValueAssessmentNotes
Debt-to-asset ratio53.4% (2026-06-30)AverageLeverage is at a moderate level; short-term solvency pressures still warrant monitoring.
Current ratio0.88x (2026-06-30)WatchCurrent liabilities exceed current assets, with net current liabilities of RMB 5.093 billion.
Net borrowingsRMB 13.490 billion (2026-06-30)WatchBorrowings were approximately RMB 30.723 billion, against cash and bank balances of approximately RMB 17.233 billion.
Operating cash flow / net profit attributable to shareholders5.66x (FY 2025)GoodCash flow coverage of reported profit was high, although annual profit was affected by impairments.
ROEApproximately 3.8% (FY 2025)WatchAnnual returns were low due to the low profit base and impairments.
ROE (annualized estimate)Approximately 11.7% (1H 2026)AverageSimple annualization of half-year profit; seasonality and one-off items are not adjusted for.

4. Valuation and Market Expectations

4.1 Valuation

MetricCurrentHistorical RangePeer Comparison
PE (latest full fiscal year)37.04x— (insufficient historical data on a like-for-like basis)Industry approximately 31.12x (2026-09-03, same-platform snapshot)
PE (2026 forecast)Approximately 11.6xPE (latest full fiscal year) is 37.04x; insufficient historical data on a like-for-like basis, so historical positioning cannot yet be assessed.—
PB (latest period)1.41x— (insufficient historical data on a like-for-like basis)Industry approximately 1.09x (2026-09-03, same-platform snapshot)
PS (latest full fiscal year)0.7x— (insufficient historical data on a like-for-like basis)—

Valuation multiples were calculated programmatically based on the 2026-10-07 closing data (PE/PS based on the latest full fiscal year and PB based on the latest period); peer multiples were calculated on the same basis using 2026-10-07 closing data.

Market-implied expectations: At the current PE of 37.04x, if investors require an annualized return of 9% and assume a PE of 15x in 10 years, EPS would need to grow by approximately 19.3% annually (excluding dividends; a conservative assumption). Short-term institutional net profit forecasts and this long-term EPS growth rate differ in both time horizon and metric, so they are not directly comparable.

PE is 37.04x, PB is 1.41x, and PS is 0.70x; the lack of historical data on a like-for-like basis makes it impossible to assess historical valuation percentiles. The share price implies an assumption of 19.3% average annual EPS growth over 10 years; consensus net profit growth forecasts for 2027–2028 are 11.2% and 8.5%, respectively. The periods and metrics differ, so the figures are not directly comparable.

4.2 Consensus Estimates

YearRevenueNet Profit Attributable to ShareholdersNet Profit GrowthEarnings per Share (EPS)
2026RMB 88.385–88.5 billionRMB 4.946 billion—RMB 1.267
2027RMB 93.504 billionRMB 5.502 billion+11.2%RMB 1.42
2028RMB 98.143 billionRMB 5.972 billion+8.5%RMB 1.53

The profit consensus mean and range are from ET Net; the page does not list the number of valid estimates or the data cutoff date. Revenue estimates are from Stockstar; for 2026, an S&P average of approximately RMB 88.5 billion provides additional support, while 2027–2028 estimates are from a single source.

4.3 Institutional Views

Investing.com aggregates estimates from 26 analysts, with an average target price of HKD 23.30 and a range of HKD 18.29–27.08; the most recently listed target price is HKD 27 from Haitong International on 2026-09-02.

InstitutionRatingDateNotes
Haitong InternationalOutperform2026-09-02Target price of HKD 27.00
Shenwan HongyuanBuy2026-09-07No target price listed; 2026 profit forecast is below the consensus average
MacquarieBuy2026-08-28Target price of HKD 25.00
UOBBuy2026-08-28Target price of HKD 24.40
UBSBuy2026-08-26Target price of HKD 22.00

5. Catalysts and Recent Events

5.1 Key Upcoming Events

TimingEventKey Points
2026-11-01Expiry of the share repurchase suspension periodWatch whether the company resumes repurchases and the scale of subsequent buybacks; cumulative repurchases accounted for 0.165% of issued shares as of October 6.
Late October 2026 (estimated)Milkground to release its third-quarter reportMonitor operating data and growth trends related to the cheese business; the estimated disclosure timing is based on the usual schedule in prior years and has not been confirmed.
Late March 2027 (estimated)Mengniu to announce FY 2026 resultsThe company has not yet announced a specific date; watch whether full-year revenue meets its mid-single-digit growth guidance, as well as profit and final dividend arrangements.

5.2 Recent Significant Events

  • 2026-08-26 Interim results and full-year guidance (neutral): The company said market conditions would gradually improve in 2H and maintained its mid-single-digit revenue growth guidance for the full year; no interim dividend was declared, and an RMB 319.9 million tax adjustment affected net profit attributable to shareholders.
  • 2026-10-06 Cumulative repurchases of 6.413 million shares under the authorization (positive): As of October 6, a cumulative 6.413 million shares had been repurchased since the authorization on June 5, accounting for 0.165% of issued shares on the date the authorization was approved; the repurchased shares are intended to be cancelled but have not yet been cancelled.

6. Bull-Bear Debate and Risks

6.1 Bull Case

  • Cheese grew 21.9% and ice cream grew 4.2% in 2025; expansion into these categories could gradually reduce reliance on liquid milk.
  • Operating cash flow was 5.66x net profit attributable to shareholders in 2025, indicating good cash coverage of reported profit.

6.2 Bear Case

  • Liquid milk accounted for 78.9% of revenue and declined 11.1% in 2025; if demand does not stabilize, other categories may not be able to fully compensate.
  • ROE was approximately 3.8% and net margin was 1.88% in 2025, indicating weak returns; the valuation requires subsequent earnings improvement for support.

6.3 Other Risks

  • A rebound in raw milk prices → weaker support for gross margin from the 2025 cost improvement, potentially slowing the profit recovery.
  • The provision for impairment of receivables has risen to RMB 514.9 million → further deterioration in collections would increase credit impairment and weigh on profit.
  • The latest turnover rate is only 0.19% → when trading liquidity is weak, large trades could amplify share-price volatility and valuation discounts.

7. Monitoring Checklist

IndicatorCurrentBullish ConfirmationBearish Confirmation
Liquid milk revenue growthDeclined 11.1% year over year in 2025Turns positive in subsequent disclosures or the decline narrows for consecutive periodsThe decline widens or remains in double digits
Delivery of full-year revenue guidanceCompany maintains mid-single-digit growth guidance2026 revenue achieves mid-single-digit growthFull-year revenue still declines year over year
Gross margin40.8% in 1H 2026, down year over yearRecovers in subsequent reporting periods and exceeds 40.8%Continues to decline without a corresponding improvement in revenue growth
Provision for impairment of receivablesRMB 514.9 million at the end of 2025Provision declines and collections improve in subsequent periodsProvision continues to rise

8. Share Price and Short-Term Outlook (Next Week, Scenario Analysis for Reference Only)

⚠️ Risk Warning: The following is a subjective scenario analysis based on current technical and fund-flow conditions. The assigned weights are based on experience, not statistical probabilities.

8.1 Technical Overview

The share price is below all major moving averages and has fallen 6.49% over the past 20 trading days, indicating a weak technical setup; the RSI is low but not extremely oversold, and whether support around 17.14–17.21 holds is key in the short term.

IndicatorValueInterpretation
Change over the past 5/20 trading days-3.24% / -6.49%Short-term trend is weak.
Moving averagesMA5 17.46 / MA10 17.64 / MA20 17.83 / MA60 18.23The share price is below all moving averages, with a bearish alignment.
MACD (12,26,9)DIF -0.214 / DEA -0.156 / histogram -0.116The negative histogram widened slightly from the previous day, indicating weak momentum.
RSI6 / RSI14RSI6 33.0 / RSI14 39.2Weak, but not in an extreme oversold zone.
Bollinger Bands (20,2)Upper band 18.45 / middle band 17.83 / lower band 17.21The share price is near the lower band; 17.21 is a short-term level to watch.

8.2 Key Price Levels

LevelRangeNotes
Short-term resistanceHKD 17.45–18.00Corresponds to MA5/MA10 and MA20 and the Bollinger middle band; if reclaimed, 18.23–18.45 could be in view.
First supportHKD 17.14–17.21Corresponds to the recent low and the Bollinger lower band; a decisive break would increase downside pressure.
Strong supportHKD 16.80–16.90Corresponds to the 20-day low of 16.85; a break could open up the 16.50–16.60 range.

8.3 One-Week Range Based on Historical Volatility

Using the 2026-10-07 price of HKD 17.30 as the base, the closing price range for the next 5 trading days is estimated from the return distribution over the past 300 trading days (scaled to an approximately 1.3% daily volatility under current index weighting, while retaining this stock’s own frequency of large rises and falls):

Coverage ProbabilityPrice RangeRelative to Base
Approximately 68%16.83–17.84-2.7% to +3.1%
Approximately 95%16.36–18.37-5.4% to +6.2%

This range reflects only the recent volatility of this stock and does not indicate a price direction; actual performance may still exceed the range in the event of a major announcement or a sharp market decline.

8.4 Scenarios for the Next Week (Subjective Weights, Not Statistical Probabilities)

  • Range-bound consolidation (relatively higher weight, approximately 50%): HKD 17.10–17.90; trading value remains around HKD 100–220 million, support at 17.14–17.21 holds, and the broader market does not weaken materially. Based on historical volatility, the probability of the closing price being in this range one week later is approximately 55%.
  • Downside bias (medium weight, approximately 30%): HKD 16.80–17.15; if the stock closes below 17.14 on higher volume and southbound flows resume consecutive net selling or short-selling pressure remains elevated. Based on historical volatility, the probability of the closing price being in this range one week later is approximately 20%.
  • Rebound and strengthening (relatively low weight, approximately 20%): HKD 17.83–18.20; if the stock recovers and holds above 17.46–17.64 for two consecutive days on higher volume, alongside positive industry news or accelerated share repurchases. Based on historical volatility, the probability of the closing price being in this range one week later is approximately 10%.

The weights in parentheses are subjective; the probabilities at the end of each sentence are inferred from the volatility ranges above and reflect volatility only, not price direction.

8.5 Fund Flows and Liquidity

From 2026-09-15 to 2026-10-07, daily trading value was approximately HKD 99–319 million and turnover was approximately 0.13%–0.46%; the latest figures were HKD 129 million and 0.19%. Shareholder data as of 2026-06-30 (disclosed on September 25): COFCO-related entities held 24.54%; BlackRock disclosed a 5.91% holding on August 26. No public funds, social security funds, or QFIIs were listed among the major shareholders; disclosures are lagged, so the ownership structure may have changed. Southbound investors were net sellers of approximately 57.46 million shares over the 20 days through September 21. Trading activity is relatively low and market depth is limited; large, consecutive trades could amplify volatility.

If daily trading value remains above HKD 300 million and the share price closes above the MA5 of HKD 17.46, this could be monitored as a signal of renewed fund inflows.

The above scenario analysis is based on the closing data, historical prices, and technical indicators as of 2026-10-07. Short-term share-price performance may also be affected by news, fund flows, broader market conditions, and other factors. Technical indicators are inherently lagging and limited; this analysis does not guarantee actual future performance and does not constitute a buy or sell recommendation. Please make your own independent assessment based on the latest market information and assume the associated investment risks.

Sources


This report was automatically researched, compiled, and generated by AI based on publicly available sources. Information is current as of the 2026-10-07 close and may differ in timeliness; please refer to the company’s formal announcements and authoritative data terminals for specific figures. This report is for informational and research reference only and does not constitute any investment advice. Investors should make their own independent judgments and assume the associated investment risks.

Reports are generated by AI from public online information and may contain errors or outdated information. They are for research only, not investment advice. Verify material facts against company filings and authoritative sources.